The Wall Street Journal reported that the University of Oxford announced that it had suspended testing of the COVID-19 vaccine in children and adolescents aged 6-17 years that the school had developed with the pharmaceutical firm AstraZeneca.
|The AstraZeneca vaccine stopped testing in children.|
Accordingly, the trial was halted after controversy surrounding the AstraZeneca pharmacy’s COVID-19 vaccine suspicion that caused blood clots in some patients.
No safety issues were identified in this childhood vaccine trial, but greater fears of blood clotting problems in adults have triggered these events, an Oxford University spokesman said. Further legal review in the UK and Europe, to probe any potential link for coagulopathy with the AstraZeneca vaccine.
The newspaper “The messenger” (Il Messagero) of Italy published an interview with the head of the vaccine division of the European Pharmaceutical Authority (EMA), Mr. Marco Cavaleri in which Mr. Cavaleri stated “maybe confirms that there is a clear link between the AstraZeneca vaccine and coagulation phenomenon in some vaccinated patients, but the exact cause is still unclear.
Immediately after the announcement was made, a leading British epidemiologist, Professor Neil Ferguson of the Royal College of London, told the British BBC that there is growing evidence that there is a risk. The rarity of the AstraZeneca vaccine can lead to blood clotting, and this risk may be related to the age or sex of the person getting the vaccine.
However, in an official statement released on the afternoon of April 6, the EMA said the agency has yet to come to a final conclusion on whether the AstraZeneca vaccine is the cause of the clotting phenomenon in some diseases. whether or not and will soon hold a press conference on April 7 or April 8 to announce.
Earlier, the EMA said it was investigating the incident that occurred to patients receiving an AstraZeneca vaccine series in several EU countries who subsequently had complications of thromboembolism.
Several European countries, including Austria, Estonia, Lithuania, Latvia, Luxembourg, Denmark, Bulgaria, Norway, Iceland, Slovenia, Cyprus, Italy, France, Germany and Spain have stopped using the AstraZeneca vaccine. The EMA then recommended continued use of the AstraZeneca vaccine, after which a number of countries continued to vaccinate using the product.
Brazil discussed to produce Russian vaccines
Russian President Vladimir Putin and his Brazilian counterpart Jair Bolsonaro held a phone call on April 6 to discuss the prospects of developing bilateral relations as well as practical cooperation issues in the fight against the coronavirus, including the registration and production of Russian vaccine Sputnik V in Brazil.
|Russian President Vladimir Putin and his Brazilian counterpart Jair Bolsonaro were on the phone.|
“A phone call between Russian President Vladimir Putin and Brazilian President Jair Bolsonaro has been initiated by the Brazilian side. An active commitment to joint operations in line with the Russian-Brazilian strategic partnership has been reaffirmed” – an announcement from the Kremlin said.
Accordingly, the two sides agreed to carry out practical cooperation in the fight against the spread of the global pandemic.
The two leaders also discussed the registration and production of Russia’s Sputnik V vaccine in Brazil.
“President Jair Bolsonaro on April 6 called Russian President Vladimir Putin. The parties discussed issues of purchasing Sputnik V vaccine and the production of this vaccine in Brazil, bilateral trade issues, cooperation. in the defense sector, in science and technology, President Bolsonaro stressed the need to increase the number of Brazilian companies allowed to export their meat products. [sang Nga]”- a notice from the Kremlin stated clearly.